These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8632622)

  • 1. Cardiogenic shock following recombinant alpha-2b interferon therapy for chronic hepatitis C. A case report.
    Teragawa H; Hondo T; Amano H; Watanabe H; Ohe H; Hattori N; Watanabe Y; Hino F; Ohbayashi M
    Jpn Heart J; 1996 Jan; 37(1):137-42. PubMed ID: 8632622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C.
    Fukumoto Y; Shigemitsu T; Kajii N; Omura R; Harada T; Okita K
    Intern Med; 1994 Oct; 33(10):637-40. PubMed ID: 7827383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic hepatitis C with recombinant interferon alfa-2b.
    Piazza M; Orlando R; Tosone G; Tiseo D; Conte MC; Minervini F; Santoro G; Scordino F; Vitale D
    Gut; 1993; 34(2 Suppl):S128-9. PubMed ID: 8314479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of chronic active hepatitis C presenting heart failure during interferon alpha 2 alpha therapy].
    Shinagawa J; Inagaki Y; Suzuki M; Atsukawa K; Yonei Y; Tsukada N; Miyamoto K; Suzuki O; Kawamura Y; Kiryu Y
    Nihon Shokakibyo Gakkai Zasshi; 1995 May; 92(5):899-903. PubMed ID: 7783385
    [No Abstract]   [Full Text] [Related]  

  • 5. Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha.
    Veerabagu MP; Finkelstein SD; Rabinovitz M
    Dig Dis Sci; 1997 Jul; 42(7):1445-8. PubMed ID: 9246044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation of primary biliary cirrhosis during interferon-alpha 2b therapy for chronic active hepatitis C.
    Maeda T; Onishi S; Miura T; Iwamura S; Tomita A; Saibara T; Yamamoto Y
    Dig Dis Sci; 1995 Jun; 40(6):1226-30. PubMed ID: 7781437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B/type C hepatitis after transfusion.
    Colombo M; Lampertico P; Rumi M
    Gut; 1993; 34(2 Suppl):S141. PubMed ID: 8314483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoidosis after interferon therapy for chronic active hepatitis C.
    Teragawa H; Hondo T; Takahashi K; Watanabe H; Ohe H; Hattori N; Watanabe Y; Amano H; Hino F; Ohbayashi M; Urushihara T; Yonehara S
    Intern Med; 1996 Jan; 35(1):19-23. PubMed ID: 8652926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of recombinant interferon alfa-2b in elderly patients with anti-HCV-positive chronic active hepatitis.
    Bresci G; Del Corso L; Romanelli AM; Giuliano G; Pentimone F
    J Am Geriatr Soc; 1993 Aug; 41(8):857-62. PubMed ID: 7688007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C.
    Tada H; Saitoh S; Nakagawa Y; Hirana H; Morimoto M; Shima T; Shimamoto K; Okanoue T; Kashima K
    J Gastroenterol; 1996 Aug; 31(4):582-4. PubMed ID: 8844482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C.
    Chin K; Tabata C; Sataka N; Nagai S; Moriyasu F; Kuno K
    Chest; 1994 Mar; 105(3):939-41. PubMed ID: 8131569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C.
    De Bac C; Grimaldi F; Clementi C; Duca F; Livoli D; Taliani G
    Gut; 1993; 34(2 Suppl):S135. PubMed ID: 8314480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection.
    Schlesinger TE; Camisa C; Gay JD; Bergfeld WF
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):1023-5. PubMed ID: 9204077
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
    Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, double-blind, randomized study.
    Villa E; Trande P; Grottola A; Buttafoco P; Rebecchi AM; Stroffolini T; Callea F; Merighi A; Camellini L; Zoboli P; Cosenza R; Miglioli L; Loria P; Iori R; Carulli N; Manenti F
    Dig Dis Sci; 1996 Jun; 41(6):1241-7. PubMed ID: 8654159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C complicated by Coombs-negative hemolytic anemia during interferon treatment.
    Hirashima N; Mizokami M; Orito E; Yamauchi M; Narita M; Mizuno M; Tokuda Y; Nakano T; Kato M; Matsumoto T
    Intern Med; 1994 May; 33(5):300-2. PubMed ID: 7949634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hazards of interferon therapy for HBV-seronegative chronic hepatitis.
    Vento S; Di Perri G; Garofano T; Cosco L; Concia E; Ferraro T; Bassetti D
    Lancet; 1989 Oct; 2(8668):926. PubMed ID: 2571851
    [No Abstract]   [Full Text] [Related]  

  • 18. Appearance of oral erosive lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
    Núñez M; Miralles ES; de las Heras ME; Ledo A
    J Dermatol; 1995 Jun; 22(6):461-2. PubMed ID: 7650248
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interferon induced IBD-like acute colitis--two cases of patients with chronic active hepatitis].
    Yamamoto Y; Sakatani N; Yano S; Kou K; Ochi S; Yoshida Y; Fujimoto R; Ohno K; Sawai S
    Nihon Shokakibyo Gakkai Zasshi; 1995 Sep; 92(9):1293-6. PubMed ID: 7474487
    [No Abstract]   [Full Text] [Related]  

  • 20. [A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C].
    Fernández I; Castellano G; Canga F; Colina F; García H; Fuertes A; Casis B; Martín A; Solís JA
    Gastroenterol Hepatol; 1995 Feb; 18(2):66-72. PubMed ID: 7621277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.